Avastin Articles

Stock Commentary - New York

21 July 2003

Roche obtains Avastin rights outside USA from Genentech

14 July 2003

Genentech swings to profit as sales soar

14 July 2003

Genentech's Avastin on fast-track program

7 July 2003

Stock Commentary - Europe

9 June 2003

Stock Commentary - New York

9 June 2003

Genentech's Avastin improves survival in metastatic colorectal cancer

9 June 2003

Stock Commentary - Europe

2 June 2003

Stock Commentary - New York

2 June 2003

New York Stock Comment

26 May 2003

FDA panel recommends approval of the biologic Xolair for asthma

26 May 2003

Genentech soars as cancer drug Avastin meets and exceeds expectations

26 May 2003

Avastim raises antiangiogenesis hopes

27 May 2002

Roche pipeline set to deliver renewed momentum after 2004

6 May 2002

Pharmacia drops colorectal cancer drug semaxanib in late-stage trials

18 February 2002

Analyst considers impact that loss of US Accutane patent will have on Roche

4 February 2002

Genentech expects quiet 2002

14 January 2002

Stock Commentary - New York

1 November 2001

Genentech boosted by Avastin study

26 October 2001

Antisoma: strong fundamentals belie near-term financing troubles

10 October 2001

Showing 401-420 of 420 articles

Go to beginningPreviousNextGo to end